Saul M. Schanberg, Joseph J. Schildkraut, G. Breese
Feb 1, 1968
Citations
1
Influential Citations
351
Citations
Quality indicators
Journal
Biochemical pharmacology
Abstract
Abstract Normetanephrine-H 3 injected into the cisterna magna of rats is rapidly metabolized and disappears from brain with an initial half-life of about 12 min. Monoamine oxidase inhibition prevents almost completely the conversion of normetanephrine-H 3 to other metabolites and markedly diminishes the rate of disappearance of radioactivity from brain ( T 1 2 = 2·4 hr ) . These data show that normetanephrine is normally metabolized primarily by monoamine oxidase and that unaltered normetanephrine does not readily pass out of the brain. Free 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3-methoxy-4-hydroxymandelic acid (VMA) formed from intracisternally injected normetanephrine-H 3 represent only a small fraction of the radioactivity in brain. The major metabolite was identified as the sulfate conjugate of MHPG. After intracisternal administration of norepinephrine-H 3 , 3-methoxy-4-hydroxyphenylglycol sulfate (MHPG-SO 4 ) was also found to be the major metabolite present in brain. These findings suggest that deamination, reduction, and subsequent conjugation with sulfate is the primary route of metabolism of normetanephrine in rat brain and that norepinephrine is also metabolized to this sulfate conjugate.